These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 4679896)

  • 1. Turnover of endogenous parathyroid hormone in uremic patients and those undergoing hemodialysis.
    Massry SG; Coburn JW; Peacock M; Kleeman CR
    Trans Am Soc Artif Intern Organs; 1972; 18(0):416-22. PubMed ID: 4679896
    [No Abstract]   [Full Text] [Related]  

  • 2. Hyperparathyroidism and renal failure.
    Arnaud CD
    Kidney Int; 1973 Aug; 4(2):89-95. PubMed ID: 4598144
    [No Abstract]   [Full Text] [Related]  

  • 3. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Skeletal resistance to the calcaemic action of parathyroid hormone in uraemia: a mechanism for the hypocalcaemia and secondary hyperparathyroidism of chronic renal failure.
    Massry SG
    Clin Endocrinol (Oxf); 1976; 5 Suppl():317S-325S. PubMed ID: 1052781
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of hemodialysis on secondary hyperparathyroidism in patients with chronic renal failure.
    Johnson JW; Hattner RS; Hampers CL; Bernstein DS; Merrill JP; Sherwood LM
    Metabolism; 1972 Jan; 21(1):18-29. PubMed ID: 5008012
    [No Abstract]   [Full Text] [Related]  

  • 6. Non-suppressible parathyroid hormone secretion is related to gland size in uremic secondary hyperparathyroidism.
    Indridason OS; Heath H; Khosla S; Yohay DA; Quarles LD
    Kidney Int; 1996 Nov; 50(5):1663-71. PubMed ID: 8914034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Total parathyroidectomy: parathyroid hormone levels and supernumerary glands in hemodialysis patients.
    Meakins JL; Milne CA; Hollomby DJ; Goltzman D
    Clin Invest Med; 1984; 7(1):21-5. PubMed ID: 6723120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-suppressible secondary hyperparathyroidism in chronic progressive renal disease.
    Slatopolsky E; Rutherford WE; Hoffsten PE; Elkan IO; Butcher HR; Bricker NS
    Kidney Int; 1972; 1(1):38-46. PubMed ID: 5075944
    [No Abstract]   [Full Text] [Related]  

  • 9. Parathyroid growth and suppression in renal failure.
    Lewin E; Huan J; Olgaard K
    Semin Dial; 2006; 19(3):238-45. PubMed ID: 16689976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma parathormone, calcium and phosphorus in patients with renal osteodystrophy undergoing chronic hemodialysis.
    Genuth SM; Sherwood LM; Vertes V; Leonards JR
    J Clin Endocrinol Metab; 1970 Jan; 30(1):138-40. PubMed ID: 5409532
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of calcium and phosphorus on patients maintained on dialysis.
    Goldsmith RS; Arnaud CD; Johnson WJ
    Kidney Int Suppl; 1975 Jan; (2):118-22. PubMed ID: 1099298
    [No Abstract]   [Full Text] [Related]  

  • 12. Parathyroid suppressibility in hyperparathyroidism due to chronic renal failure: studies with autotransplanted parathyroid tissue.
    Born W; Dambacher MA; Meyrier A; Ardaillou R; Fischer JA
    Clin Endocrinol (Oxf); 1982 Oct; 17(4):333-43. PubMed ID: 6754143
    [No Abstract]   [Full Text] [Related]  

  • 13. Renal osteodystrophy and vitamin D derivatives: cellular mechanisms of hyperparathyroidism in uremia.
    Fukagawa M; Kurokawa K
    J Nutr Sci Vitaminol (Tokyo); 1992; Spec No():96-9. PubMed ID: 1338454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cimetidine in the treatment of secondary hyperparathyroidism in uremia treated with hemodialysis].
    Antonucci F; Gropuzzo M; Messa PG; Montanaro D; Adorati M; Paviotti G; Favazza A; Susanna F; Zilli M; Mioni G
    Minerva Med; 1985 Mar; 76(9-10):403-6. PubMed ID: 3885074
    [No Abstract]   [Full Text] [Related]  

  • 15. Parathyroid function in uremic children with and without osteodystrophy.
    Roof BS; Piel CF; Rames L; Potter D; Gordan GS
    Pediatrics; 1974 Mar; 53(3):404-9. PubMed ID: 4815261
    [No Abstract]   [Full Text] [Related]  

  • 16. Parathyroid hormone metabolism and its potential as a uremic toxin.
    Slatopolsky E; Martin K; Hruska K
    Am J Physiol; 1980 Jul; 239(1):F1-12. PubMed ID: 6994509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between magnesium and secondary hyperparathyroidism during long-term hemodialysis.
    Pletka P; Bernstein DS; Hampers CL; Merrill JP; Sherwood LM
    Metabolism; 1974 Jul; 23(7):619-30. PubMed ID: 4600477
    [No Abstract]   [Full Text] [Related]  

  • 18. [PTH and bone metabolism in chronic dialysis patients].
    Fukagawa M; Kazama J; Shigematsu T
    Rinsho Byori; 2001 Mar; 49(3):236-8. PubMed ID: 11307321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased parathyroid expression of klotho in uremic rats.
    Hofman-Bang J; Martuseviciene G; Santini MA; Olgaard K; Lewin E
    Kidney Int; 2010 Dec; 78(11):1119-27. PubMed ID: 20631679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Parathyroidectomy in secondary hyperparathyroidism in chronic uremic patients under dialysis treatment. Development of the surgical strategy].
    Zucchi C
    Minerva Med; 1985 Mar; 76(9-10):397-401. PubMed ID: 3982697
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.